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ABSTRACT

Production and Purification of Recombinant Minor Ampullate Silk Proteins

by

Danielle A. Gaztambide, Master of Science
Utah State University, 2018

Major Professor: Randolph V. Lewis, Ph.D.
Department: Biological Engineering
Spider silks long have been recognized as some of nature’s most impressive
materials. By divergent evolution, orb-weaving spiders produce and utilize six distinct
silk fibers and one glue for a variety of biological roles. Each silk is the product of
proteins, highly conserved across species, called spidroins. Because it is not possible to
farm spiders, these proteins must be produced synthetically in order to study the protein
sequences and use these proteins for material applications.
This research uses Escherichia coli (E. coli) as a production system to investigate
the first known expression and purification of synthetic minor ampullate silk, a lesser
studied silk the spider uses to make up the auxiliary spiral of the orb web. The auxiliary
spiral creates a template for the capture spiral and provides additional stability during
web construction. Natural minor ampullate silk has a high tensile strength, does not
supercontract in water, and is inelastic with fiber properties similar to Kevlar. This
investigation completes the construction and expression of six synthetic analogs of minor
ampullate silk protein ranging from 40 to 134 kilodaltons (kDa). Using fed-batch aerobic
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fermentation, this thesis investigates the efficacy and optimization of E. coli as a
production platform for recombinant minor ampullate silk proteins. This study also
develops purification protocols for these proteins following production and performs the
first preliminary characterization of synthetic recombinant minor ampullate silk proteins
based on sequence and molecular weight.
(93 pages)
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PUBLIC ABSTRACT

Production and Purification of Recombinant Minor Ampullate Silk Proteins
Danielle A. Gaztambide

Spider silks are incredible natural materials that have a wide variety of properties
that can rival or outperform even common synthetic materials like Nylon and Kevlar. As
nature’s architects, orb-weaving spiders spin seven different silks that are used for very
specific roles throughout the spider’s lifecycle. These silks are comprised of proteins
called spidroins. Each of these spidroins has evolved to have properties such as strength
and/or stretch that make these silks successful and highly adapted in their designated
roles in web construction, prey capture and reproduction.
This study involves the production of minor ampullate silk by genetically
modifying the bacteria Escherichia coli. Minor ampullate is a lesser studied silk that is
used for the first spiral of the orb web. This spiral is a template that the spider uses to
finish the web and provides stability during the web construction. Minor ampullate silk is
strong, however it does not stretch so it may be well-suited for certain applications such
as ballistic materials.
By producing and purifying different arrangements of minor ampullate silk
protein, it is possible to learn how this protein can be expressed without using the spider
itself. This investigation sheds light on how deviations in the protein sequence and motif
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arrangement can produce different properties, which can potentially be used to make new
materials.
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CHAPTER 1
INTRODUCTION

NATIVE SPIDER SILKS
Since ancient times, spider silk has inspired intrigue with its strength, elasticity,
toughness, ductility, thermostability, and biocompatibility when compared with both
natural and synthetic materials. All 41,000 species of spiders produce and utilize silk.
Depending on the species, they use silk for a variety of biological acts including prey
capture, prey wrapping, shelter, egg casings, mating, and even parachuting1. Most spiders
spin more than one type of silk. Notably, the orb-weavers are the best representation of
millions of years of gene duplication and divergence that led to the variety of silks that
these spiders utilize today2.
Female orb-weaving spiders produce six distinct silk fibers and one glue. Each
originates from a separate silk gland in the spider’s abdomen as Figure 1-1 demonstrates.
These silks include: major ampullate (dragline and web radii); minor ampullate
(temporary auxiliary spiral); flagelliform (capture spiral); aggregate (aqueous glue);
piriform (fiber attachment); aciniform (prey wrapping); and tubuliform (egg sacs and
cocoons)3. Major ampullate silk proteins traditionally have been the most studied spider
silk proteins due to their impressive combination of strength and elasticity that result in a
toughness two to three times greater than synthetic fibers such as Kevlar and nylon.
However, each of the silks possess different mechanical properties that may be ideally
suited for material applications as diverse as ballistic material and very fine sutures4.
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Figure 1-1. Spider silk glands and silk biological roles

Table 1-1 illustrates how these silks compare with each other and with other
natural and synthetic fibers5. Natural minor ampullate silk has properties similar to
Kevlar and tendon, due to its high tensile strength (1 x 109 N/m2) and decreased
elongation.
The self-assembling fibroins that make up these silks result in a diverse set of
fibers with mechanical properties that are functionally related to their amino acid motifs
and thus protein sequence and folding structures6. In nature, spider silk proteins are large
(~350 kDa) and include nonrepetitive N- and C-termini, with the rest of the sequence
consisting entirely of repetitive amino acid motifs.
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Table 1-1: Fiber mechanical property comparisons.

The N-terminus has a role in transport and encodes a signal peptide7; however, the
role of the highly conserved C-terminus has remained somewhat elusive, with some
investigations showing that it may be important for stability in the gland and fiber
formation8. There are four types of shared amino acid motifs among the spider silk
proteins: GPGGX/GPGQQ, GGX, poly-A/poly-Gly-Ala, and a nonrepetitive spacer
region3. While much of the structure-to-function relationship in spider silks has remained
elusive, fiber x-ray diffraction and nuclear magnetic resonance spectroscopy has shown
that the poly-alanine and (GA)n repeats correlate to crystalline β-sheet structures, while
the glycine-rich (GGX) repeats form GlyII-helices9. The GPGGX regions primarily
found in major ampullate silk correlate to β-spiral structures, providing the dragline silk
its elasticity10.
Substantial sequence information for the minor ampullate spidroins (MiSps) was
first published in 1997 and has since been corroborated by additional investigations;
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however, there are currently no published investigations of synthetic analogs of these
spidroins12. Minor ampullate silk, like many of the spider silks, is comprised of two
proteins: MiSp1 (9.5 kb) and MiSp2 (7.5 kb)13,14. These two spidroins have similar
repetitive regions; however, MiSp2 has a shorter and less conserved repetitive region
when compared with MiSp1. Nevertheless, the repetitive regions in the MiSps are more
highly conserved than either of the major ampullate silk proteins13. These repetitive
regions of the MiSps sequence resemble amorphous regions in the heavy chain of the
Bombyx mori silkworm15. MiSp1 and MiSp2 also contain identical 137 amino acid
nonrepetitive spacer regions that occur every 10 repeats and are not homologous to any
other spider silk sequence.13 No secondary structure has been definitively assigned to this
spacer region, however it is hypothesized to be the cause of the inelasticity of the
resulting MiSp fiber and contains long stretches of α-helical structures16. Figure 1-217

Figure 1-2. Secondary structures assigned to the prevalent motifs in spider silks
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illustrates the secondary structures that have been assigned to the amino-acid motifs in
spider silks. The repetitive motifs in MiSps include GX, GGX, GGGX and shorter
poly-alanine repeats, when compared with major ampullate silk. While the repetitive
sequence in MiSp is similar to major ampullate spidroin 1 (MaSp1), the longer polyalanine repeats seen in major ampullate spidroins (MaSps) are replaced by (GA)n repeats
in minor ampullate silk. The sequence hierarchy of minor ampullate silk proteins from
the Nephila clavipes spider is illustrated in Figure 1-313. This sequence organization is
hypothesized to be the cause for the decreased tensile strength seen in MiSps, as the
(GA)n β-sheet structures possess fewer hydrophobic interactions when compared with the

Figure 1-3. Sequence hierarchy of minor ampullate silk protein
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longer poly-alanine β-sheet structures16,18. The MiSps also have different ratios of GGX
and GA repeats and the repetitive region lacks the proline seen in MaSp2, which is
hypothesized to give major ampullate silk its elasticity9,19,20.

SYNTHETIC RECOMBINANT SPIDER SILK PRODUCTION
Due to spiders’ cannibalistic and territorial behavior, and the fact that it is difficult
to obtain specific spider silk proteins, farming spiders to study and use their silk is not
economically or practically feasible. For reference, it took eight years to make a single
spider silk cape with fibers harvested from 1.2 million orb webs21. Therefore, it is
imperative to use transgenic hosts to produce spider silk synthetically for large-scale
production of recombinant spider silk proteins (rSSps) so that these proteins may be
utilized for functional materials12,22. These transgenic hosts have included both
unicellular and multicellular organisms as heterologous hosts. While each transgenic host
has its pros and cons, spider silk proteins are inherently difficult to produce synthetically
regardless of their host due to their large size (~350 kDa) and highly repetitive
sequence21,23,24. Multicellular organisms typically produce proteins at the size scale of
spider silk proteins; however, genetic instability, protein aggregation post-translation, low
mechanical properties, low yields, and high costs remain significant problems for largescale production. Multicellular organisms that have been investigated for the expression
of spider silk proteins include goats, mice, silkworms, and plants12. A timeline of spider
silk production in a variety of hosts is shown in Figure 1-421.
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Figure 1-4. Chronological representation of synthetic recombinant spider silk
production in transgenic hosts

Because of the low cost of production, established protocols for scalability, and
ease of genetic manipulation, unicellular organisms such as bacteria, and more
specifically E. coli, have hosted most of the research into the production of synthetic
spider silk proteins25–27. E. coli is a well-suited choice for large-scale protein expression
and production because a large library of expression plasmids, molecular protocols, and
cultivation parameters that are already established28. Adding to its cost-effectiveness, E.
coli is also a much faster expression system to develop than many of the multicellular
systems described above.

8
While synthetic production of spider silk proteins has been the subject of a large
amount of investigation in recent years, most of these studies have been done with the
major ampullate silk proteins17,26,29–31. Minor ampullate silk is one of the lesser studied
silks due to the fact that the minor ampullate gland is much smaller and thus harder to
isolate than the major ampullate gland. Minor ampullate fibers also typically have smaller
diameters than the major ampullate silk fibers and their biological role is not as readily
understood19. As well, based upon evidence presented in this thesis, it is very possible
that when expressed in E. coli the proteins become so insoluble as to be unrecoverable by
common methods. In essence, their levels of insolubility make it appear as if no protein
was expressed. This may be one of the leading reasons for the lack of study of
recombinant forms of other spider silk proteins like the minor ampullate silk proteins.
Aside from the type of spider silk being produced, there are also many other
hurdles to protein expression for synthetic spider silk proteins that are the result of the
large size and repetitive nature of the protein sequence. Minimizing truncation of these
high molecular weight products will need to be considered, as translation pauses and
proteolytic degradation are all factors for high-density, cell culture expression of these
repetitive proteins12,17,21–23,28,32. These proteins also have a tendency to fold incorrectly
post-translation and, due to their self-assembling nature, create insoluble aggregates in a
manner similar to inclusion bodies21. These aggregated proteins create even more
challenges for purification, as the solubility and protein-protein interactions can defy
conventional purification techniques such as affinity chromatography.
Producing these large proteins in a cost-effective manner will also be a deciding
factor if spider silk is to replace synthetic fibers such as nylon or Kevlar. Figure 1-533
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shows a cost-analysis profile of rSSps produced in E. coli. As you can see, the cost of
production of these rSSps depends on the capacity of the production system, an area that
has seen continuous improvement in recent years23,24.

Figure 1-5. Cost analysis for production of rSSps in E. coli. Case 1: baseline scenario.
Case 2: optimized scenario.

MATERIAL APPLICATIONS OF SPIDER SILK PROTEINS
Harnessing the properties of natural spider silk proteins synthetically will create
possibilities for new, lightweight polymer materials that outperform current synthetic and
natural materials. Figure 1-634 illustrates the native and synthetic processes for creating
these silk materials and their subsequent potential product applications. Understanding
the processing conditions necessary in synthetic systems to replicate silk properties will
be crucial for future silk production and material characterizations.
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Figure 1-6. Native and synthetic processing of spider silk materials and potential
product applications.

While the spider utilizes these proteins for mainly fiber applications, synthetic
spider silk proteins have also been solubilized in water to produce environmentally
friendly adhesives, films, sponges, lyogels, hydrogels, coatings, and fibrous mats as seen
in Figure 1-735–37. When solvated in water, these materials produce no harmful byproducts and can be modified to contain antibiotics, antimicrobials, growth factors, etc37–
39

. For comparison, Kevlar production utilizes concentrated sulfuric acid and yields

hydrochloric acid as a by-product, which translate to additional costs to store and remove
these compounds. Films have traditionally been the most studied material application
outside of fibers because they typically require less processing than fibers and have many
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Figure 1-7. Aqueous recombinant spider silk materials

diverse functional applications. Silk film applications include medical device coatings,
cell scaffolds, drug delivery systems, and in vivo implants40–44.
To the author’s knowledge, there are no published characterizations of films or
other materials using synthetic minor ampullate spider silk proteins. The solvation of
rSSps in water also has raised the possibility that spider silk may be used in medical and
other industries that restrict use of toxic substances. Previously, large and naturally
insoluble rSSps had been solvated in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), a toxic
organic solvent that disqualifies the protein products for many industrial uses. These
products typically require much less protein than fibers, which increases the costeffectiveness for material applications. Synthetic MiSps may offer new and interesting
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properties to these aqueous materials, allowing them to fill new niches in a variety of
applications.
Using the known sequence information from Nephila clavipes, this investigation
focused on: (i) the first known production of synthetic recombinant minor ampullate silk
protein analogs in genetically engineered E. coli, (ii) the purification of these silk proteins
from the soluble phase, and (iii) mechanical property characterization of thin films
derived from the purified proteins.
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CHAPTER 2
EXPRESSION AND PURIFICATION OF SYNTHETIC MINOR AMPULLATE SILK
PROTEINS

MATERIALS AND METHODS
Design and Construction of Synthetic Minor Ampullate Silk Protein Analogs
The repetitive DNA core sequence and spacer region of MiSp1, based on Nephila
clavipes, has been sequenced (GenBank:AAC14589.1) and was used for the synthetic
constructs of this investigation. Prior to this study, this repetitive sequence was codon
optimized and synthesized (Life Technologies). From this baseline construct, the next
five constructs were built using molecular biology techniques. Figure 2-1 shows the full
protein sequence used for each sequence module of the MiSps in these gene constructs. It
matches exactly the repeat consensus sequence and spacer region in MiSp1 of Nephila
clavipes shown in Figure 1-3. Notice the short poly-alanine stretches, GGX and (GA)n
residues, and non-repetitve spacer and C-terminus. The repetitive consensus sequence is
mostly composed of glycine and alanine, with highly conserved tyrosine and glutamine
residues13.
For purposes of this project, six DNA constructs were synthesized and built for
expression of minor ampullate silk proteins in E. coli (MiSp8, MiSp8s, MiSp16,
MiSp16s, MiSp24, and MiSp24s). Each construct was named in reference to how many
core MiSp repeats they contained and whether they include the spacer region(s)
indicative of these proteins in nature. Referring again to the sequence hierarchy in Figure
1-3, natural MiSps contain 10 repetitive units per repeat. The first synthetic construct will
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contain eight repetitive units (1,189 bp) as shown in the MiSp8 region of Figure 2-1. This
gene insert and all subsequent spider silk gene inserts were flanked by restriction sites
NdeI and BamHI at the N and C-terminus, respectively. The C-terminus region shown in
Figure 2-1 had been previously cloned into the chosen expression vector and thus do not
need to be included in the construction of the repetitive clones. The cloning vector that
was used for the creation and propagation of these constructs was pMK (2829 bp) and
TOP10 chemically competent cells (Thermo Fisher) were used for all subsequent
transformations during cloning.

Figure 2-1. Protein sequence information for modules of synthetic minor ampullate
silk protein constructs
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From this baseline MiSp8 construct shown in Figure 2-1, the next five silk
constructs were created using molecular biology techniques and gene synthesis. The 411
bp nonrepetitive spacer region created to match the amino acid sequence of the spacer
region of MiSps of Nephila clavipes was also optimized for E. coli and synthesized at the
N-terminus of the MiSp8 construct downstream from the NdeI and AgeI restriction sites
and in frame with the repetitive MiSp8 core sequence. This 1,595 bp construct was
named MiSp8s.
Taking advantage of the modular and repetitive nature of spider silk, the remaining gene
constructs were built from the MiSp8 and MiSp8s base constructs using compatible and
nonregenerable restriction sites to extract and combine the repetitive modules resulting in
increasingly larger DNA constructs15. Double digests were first performed on two
aliquots of the pMK-MiSp8 plasmid in order to build pMK-MiSp16, using AgeI and
NcoI on one aliquot and NcoI and BspeI on the other. The NcoI restriction site interrupts
the kanamycin resistance gene in the pMK cloning vector. Following these digests, the
two larger gene pieces from each of these digests (2,407 bp and 2,255 bp) were extracted
using a QIAquick gel extraction kit. Once extracted and purified, these oligos were
ligated using quick ligase (NEB) and transformed into One Shot TOP10 chemically
competent cells per the manufacturer’s directions (Thermo Fisher). Colonies were
incubated overnight at 37°C on an agar plate containing kanamycin (100 mg/ml) for
additional selective pressure. Single colonies were transferred to 5 ml of LB media and
incubated at 37°C for 12 hours. Plasmids were purified using a QIAGEN Plasmid
Miniprep kit. Digestion checks with BamHI and NdeI were performed on the purified
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plasmid to verify a successful ligation following agarose gel electrophoresis (0.2%
agarose) run for 35 minutes at 100 V and stained with ethidium bromide. Plasmids that
digested as expected were sequenced using the T7 forward and reverse universal primers
(ACTG Inc.) to confirm. Successful ligation of this construct resulted in a complete 4,662
bp plasmid that contained two sets of eight repeat units (MiSp16) in the pMK cloning
vector. The mechanisms of construction are shown in Figure 2-2. Restriction enzymes
AgeI and BspeI are compatible and nonregenerable. Therefore, following ligation these
enzymes only cut at the N- and C-termini of the full MiSp16 repetitive sequence, because
the site in the middle of these repeats has been eliminated. This method using compatible,
nonregenerable restriction sites allows for the construction of larger MiSps. This basic
protocol was repeated another three times to yield the final three MiSp constructs
(MiSp16s, MiSp24, MiSp24s). Double digests of AgeI with NcoI and BspeI with NcoI
were repeated on two aliquots of pMK-MiSp8s (3,900 bp). The larger DNA pieces from
each digest (2,824 bp and 2,672 bp) were extracted and ligated to yield the complete
pMK-MiSp16s plasmid (5,496 bp). This ligation resulted in two MiSp8 repeats separated
by two spacer regions (3,203 bp) because the spacer region was synthesized downstream
of the AgeI restriction site in the pMK-MiSp8s construct to make it compatible with this
protocol. To build pMK-MiSp24, these same double digests were performed again on an
aliquot of pMK-MiSp8 and an aliquot of pMK-MiSp16 and the two larger pieces of each
digest (3,587 bp and 2,255 bp) were extracted, purified, and ligated. Finally, to build
pMK-MiSp24s, these double digests were performed on two aliquots of MiSp8s and
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MiSp16s. Again, the two larger pieces from each double digest were extracted, purified,

Figure 2-2. Modular build of repetitive MiSp constructs illustrating the build from
pMK-MiSp8 to pMK-MiSp16
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and ligated (4,421 bp and 2,671 bp).
Once verified by digestion checks and sequencing, these synthetic spider silk
constructs were digested out of the pMK cloning vector using enzymes BamHI and NdeI
and ligated into a modified pET19 series expression vector that contains the nonrepetitive
spider silk C-terminus region and a 6X-histidine tag. The C-terminus region was cloned
into this vector before this project and was provided for this research (publication
pending). This in-house vector is named pET19kt (~6,000 bp).
A helper plasmid was also transformed into a stock of chemically competent
BL21(DE3) cells, which codes for three glycine tRNAs and chloramphenicol resistance
as part of a modified pACYC vector (4,245 bp). This cell stock was used for all
subsequent transformations for both flask studies and benchtop bioreactor runs. These
glycine tRNAs were expected to ease the burden of translation for the glycine-rich
repetitive constructs, because previous studies have identified that in rSSp production, E.
coli cells exhibited up-regulation for a glycine biosynthetic enzyme and the β-subunit of
glycyl-tRNA synthetase, indicating cellular stress due to the expression of these highly
repetitive silk sequences45.

Expression of Minor Ampullate Silk Proteins

Preliminary Flask Studies
The pET19kt-MiSp plasmids constructed for protein expression were pET19ktMiSp8, pET19kt-MiSp8s, pET19kt-MiSp16, pET19kt-MiSp16s, pET19kt-MiSp24, and
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pET19kt-MiSp24s. A BL21(DE3) chemically competent cell stock previously
transformed with a plasmid coding for three glycine tRNAs and chloramphenicol
resistance was made and used for transformation with the MiSp constructs. Preliminary
investigations included flask studies for all six of the synthetic MiSps to verify protein
expression and examine the expression capabilities for each protein. One liter flask
studies were done for all six proteins using Terrific Broth media (yeast 24g/L, glycerol 4
ml/L, tryptone 20 g/L, potassium phosophate monobasic 0.17 M, potassium phosphate
dibasic 0.72 M) and the antibiotics chloramphenicol (60 mg/ml) and kanamycin (100
mg/ml). Flasks were inoculated from a single-colony 10 ml overnight culture and grown
at 37°C in a baffled shaker flask at 220 RPM to an OD600 of between 0.6 and 0.8. Protein
expression was induced with 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG).
Before induction, the temperature of the culture was lowered to 30°C, 25°C, or 22°C, to
mitigate truncation and result in more full-size, spider silk protein in the soluble
fraction38. The culture was grown for four hours after induction at each of these
temperatures and hourly samples were taken. Protein expression was analyzed for each
protein by SDS-PAGE and Western blot using a 6X Anti-His primary antibody
(Rockland Scientific) and an Anti-Mouse IgG (H+L) secondary antibody (Rockland
Scientific) or a custom rSSp C-terminus antibody with a Donkey Anti-Rabbit IgG (H+L)
secondary antibody (Rockland Scientific). Blotting, antibody exposure time, and antibody
concentration were according to manufacturer’s instructions. To prepare the samples for
SDS-PAGE, hourly samples were standardized to a specific OD (50 for high-density
culture samples) and this cell suspension was then sonicated with a Qsonica Q500
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sonicator using a microtip (1/8” diameter) at 1A for 15 seconds and then centrifuged in a
benchtop centrifuge (Beckman Coulter Microfuge 18) at 18,000 rcf to yield a soluble
fraction and an insoluble fraction. The soluble fraction was added directly to 2x Laemmli
sample buffer (Bio-Rad) at a 1:1 ratio and heated at 100°C for 15 minutes prior to
loading. The insoluble fraction was resuspended in 8M urea and sonicated again for 15
seconds at 1A and then centrifuged to remove any remaining insoluble material. The
clarified solution was added to 2x Laemmli sample buffer at a 1:1 ratio and heated for 15
minutes at 100°C before sample loading.

Benchtop Bioreactor Experiments
As with the flask study experiment, a BL21(DE3) cell stock previously transformed with
the glycine helper plasmid was used for transformation with the pET19kt-MiSp
constructs. A New Brunswick BioFlo/CelliGen 115 benchtop bioreactor (BF115) was
used for all high-density culture experiments for the expression of the MiSps. This 2 L
vessel has a 1 L working volume and was assembled for fed-batch aerobic fermentation
per the manufacturer’s directions. Figure 2-3 shows the assembly of the reactor. The
reactor was autoclaved before use. Vessel media components included glucose (25 g/L),
trace metals (1x), magnesium sulfate (.002 M), yeast (5 g/L), phosphates (10 g/L),
thiamine (2.5 g/L), and 0.3% v/v antifoam. The antibiotics kanamycin (100 mg/ml) and
chloramphenicol (60 mg/ml) were added to both the vessel media and the feed media.
510 ml of feed media was made from an autoclaved 70% glucose solution at a volume of
220 ml. Additional feed media components included Hy-Express System II (0.6% v/v),
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Figure 2-3. Benchtop bioreactor setup for MiSp expression

magnesium sulfate (.012 M), thiamine (.0124 g), trace metals (0.6x), and antibiotics
kanamycin (100 mg/ml) and chloramphenicol (60 mg/ml)). A 100 ml seed culture
inoculated with the pET19kt-MiSp construct was grown to an OD600 of ~3 at 37°C and
220 RPM and used to inoculate the BF115 bioreactor for a starting OD600 ~0.3. New
Brunswick Biocommand software was used to monitor the aerobic fermentation and
programmed to start the exponential feed pump when the cells ran out of glucose (pH
spike combined with a dissolved oxygen drop).
A cascade program was set to control oxygen input, air flow, agitation, and pH
dependent on probe readout values. A separate feed pump of ammonium hydroxide was
used to maintain pH and was controlled by this cascade program. The fixed parameters
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for growth were a pH of 7.0 and a dissolved oxygen saturation of 85%. The cascade
program controlled the oxygen input and agitation to ensure 85% dissolved oxygen in the
vessel was maintained. The culture was allowed to grow at 37°C for ~8 hours or until an
OD600 of ~80 was reached. At this point, temperature in the vessel was decreased to 22°C
and the culture was induced with a final concentration of 1 mM IPTG. Following
induction, glucose concentration was kept between 5 and 10 g/l and hourly samples were
taken. The aerobic fermentation was continued for 4 hours after induction.
Hourly samples were standardized for a final OD600 of 25 by dilution with lysis
buffer (2 M urea, 20 mM Tris-HCL, 0.5 M NaCl, 2 mM EDTA) for SDS-PAGE and
Western blot analysis. Samples were prepped using the same protocol as above for the
flask study experiments.

Purification of Synthetic Minor Ampullate Silk Proteins
Purification of the four synthetic MiSps expressed in E. coli was achieved using
three main purification methods following an initial extraction and purification step. Due
to the different molecular weights and sequence information of these recombinant
proteins, purification methods had to be adapted and optimized for each construct.
Moreover, purity, solubility, and yield were factors that rendered certain methods
unviable. Purification methods included immobilized metal affinity high performance
liquid chromatography, fractional ammonium sulfate precipitations, and sequential
precipitations using ethanol, isopropanol, and acetone.
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MiSp Extraction and Initial Purification Steps
Following the harvesting of the cells from the BioFlo/Celligen 115 bioreactor, the
cell slurry was centrifuged at 11,652 rcf for 45 minutes. The cell pellet was collected and
the media was discarded. This cell pellet was weighed and 1.5x wt/vol of a urea lysis
buffer at a pH of 8 was used to suspend the cell pellet (2 M urea, 20 mM Tris-HCL, 0.5
M NaCl, 2 mM EDTA). This suspension was sonicated with a QSonica sonicator with
3/4" diameter probe at 40 A for 45 to 60 minutes or until mixture was homogenous and
cell lysis was completed. This mixture was then centrifuged at 11,652 rcf for 45 minutes
and the supernatant was collected in a 1 L glass bottle. The lysate was then heated in an
80°C water bath for 15 minutes with intermittent mixing to denature and precipitate E.
coli proteins. Polyethylenimine (PEI) was added at a final concentration of 0.2% v/v and
allowed to mix for 5 minutes to precipitate nucleic acids and then centrifuged for 1 hour
at 11,652 rcf. The supernatant was collected and stored at 4°C.

Nickel Affinity High Performance Liquid Chromatography
The polyhistidine (6X) tag at the N-terminus of the MiSp constructs was utilized
for immobilization on a Ni-NTA resin using an AKTA Avant chromatography system. A
GE XK-16 column was packed for a bed height of 14 cm. To maximize protein
solubility, accessibility of the His-tag, and to mitigate protein-protein interactions MiSp
sample solutions were prepared using a salt buffer with 2M urea, 8M urea, and/or 50%
glycerol. Running buffer compositions were adjusted accordingly to minimize rapid
concentration changes on the column. A custom program was created for the purification
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of MiSp8 using Unicorn 6.0 workstation software. This program set sample injection rate
to 1 ml/minute for slow application of sample onto the column and the flow through was
collected. The column was washed with running buffer (0.5 M NaCl, 20 mM Tris-HCL,
0.5 mM EDTA) and wash fractions were collected. 5 ml fractions were collected for 3
column volumes at 5%, 10% and 100% imidazole elutions. Samples of these fractions
were mixed 1:1 with 2x Laemmli sample buffer, heated for 15 minutes at 100 °C and
analyzed by SDS-PAGE and western blot to confirm MiSp in solution. The His-tag
antibody was used in western blotting to confirm MiSp in solution.
Following SDS-PAGE analysis to confirm MiSp in the fractions that elicited a
peak in the chromatographic spectra, both dialysis and ammonium sulfate precipitations
were performed to precipitate the MiSps. Ammonium sulfate was slowly added to the
chromatography fractions for a final saturation of 15% at 4°C. This was mixed for 35
minutes and centrifuged for 1 hour at 11,652 rcf and the pellet was collected. The pellet
was washed and agitated in diH2O until the conductivity of the supernatant was <10
microsiemens and lyophilized for storage.
As an alternative to ammonium sulfate precipitation, dialysis was performed to
remove the salts from the chromatography fractions and precipitate the MiSps as well. 30
kDa dialysis tubing (Sigma-Aldrich) containing the MiSp fractions was suspended in a
large volume of stirred ddH20 solution that was replaced every 6-8 hours for ~3 days or
until the conductivity of the dialysate remained constant. The sample was then
centrifuged for 1 hour at 11,652 rcf and the pellet was lyophilized for storage.
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Fractional Ammonium Sulfate Precipitations
Following the PEI and heat treatments, fractional ammonium sulfate
precipitations were done to target a saturation point where the MiSp precipitated, but left
most other soluble proteins and non-protein impurities in solution. Following the heat and
PEI treatments, ammonium sulfate was mixed with the clarified lysate to a final
saturation of 5% at 4°C, centrifuged at 11,652 rcf at 4°C for 45 minutes and the pellet

was discarded. The remaining supernatant was mixed with ammonium sulfate at 4°C for
a final saturation of 15%. The mixture was then centrifuged for 1 hour at 11,652 rcf and
4°C. The pellet was collected and washed with diH20 until conductivity fell below 10
microsiemens. The pellet was then lyophilized for storage and dry weight calculations.

Ethanol/Isopropanol/Acetone Precipitations
As an alternative precipitation method, ethanol, isopropanol (IPA), and acetone
precipitations were investigated to attempt to increase the solubility of the precipitated
protein without sacrificing purity.
Clarified lysates pre-treated with heat and PEI, containing MiSp8, MiSp8s,
MiSp16, and MiSp16s were first mixed with varying concentrations of cold ethanol,
centrifuged at 4°C and 8,500 rpm for 45 minutes, and tested by SDS-PAGE for presence
of MiSp in both the soluble and insoluble fractions. In the case of the larger proteins,
fractional precipitations using cold IPA and acetone were needed to precipitate the
protein as a final purification step. After SDS-PAGE analysis, protein pellets were

26
washed with 70% IPA until supernatant conductivity was below 10 microsiemens. Pellets
then were lyophilized for storage and dry weight calculations.

Preliminary Characterization of Synthetic Minor Ampullate Silk Proteins

Aqueous Recombinant Minor Ampullate Silk Films
Lyophilized MiSp protein pellet was weighed and added to distilled water for a
final concentration of 6% w/v in a sealed glass vial. The MiSps were solubilized in water
using high heat and pressure as described in previously published methods using a
microwave35. Propionic acid (99%) at a concentration of 1% v/v was added to the dope if
the protein exhibited poor solubility. Once the silk was in solution, the dope was carefully
spread onto clean 7x30 mm PDMS strips and allowed to dry (~400 ul of dope per strip).
The films were peeled off the PDMS strips for mechanical testing. No additional posttreatments were used on films before testing due to the small sample sizes at this project
stage; however, it is likely that additional treatments such as film stretching may help
enhance the film properties36,46. The films were measured for gauge length, width, and
thickness, then glued to plastic C-card testing strips across an 8 mm gap as described in
previously published methods36. Tensile testing was done using an MTS Synergie 100
machine with a 50 N load cell. The C-card was positioned on the MTS machine clamped
on both ends. The C-card was cut before testing so that only the film was being tested.
Tensile data was collected using MTS TestWorks 4 (2001) and analyzed using Microsoft
Excel for stress and strain values.
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Fourier Transform Infrared Spectroscopy
FTIR spectra were recorded using dry protein powder samples on an Agilent 660
instrument with a diamond ATR accessory. The spectra were collected with 32 scans and
a resolution of 4 cm-1. OriginPro 2018 software was used for baseline correction and
deconvolution of the spectra. The Amide I band was fitted using three Gaussian peaks
centered at 1620 cm-1 (β-sheet), 1650 cm-1 (α-helix/random coil), and 1698 cm-1 (βsheet), in accordance with the literature15,19.

Statistical Analysis
Mechanical properties were analyzed for significance using a two-tailed t-test
assuming unequal variance with a null hypothesis that sample means were equal. A pvalue of <0.05 was deemed significant.

RESULTS AND DISCUSSION

Synthetic Minor Ampullate Silk Protein Constructs
Using the build protocol outlined above in Figure 2-2, the double digests
performed to build the complete MiSp contructs are shown in Figure 2-4. These gel
extractions show the DNA pieces that were extracted and ligated together to create the
complete MiSp plasmids.
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MiSp16 Build

MiSp24 Build

MiSp16s Build

MiSp24s Build

Figure 2-4. Gel extractions used to build the pMK-MiSp constructs

Using the build protocol outlined above in Figure 2-2, the double digests
performed to build the complete MiSp contructs are shown in Figure 2-4. These gel
extractions show the DNA pieces that were extracted and ligated together to create the
complete MiSp plasmids.
Following ligation and verification by sequencing, the complete MiSp gene
constructs were removed from the pMK cloning vector and ligated into the pET19kt
expression vector. The digested expression plasmids using BamHI and NdeI are shown in
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Figure 2-5 with the pET19kt vector at ~6000 bp and the MiSp insert running below it for
each of the six inserts. Figure 2-6 shows the coding regions of these final minor
ampullate silk protein constructs, with final protein molecular weights ranging from 40 to
134 kDa.

Figure 2-5. pET19kt-MiSp digested constructs
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Figure 2-6. Coding regions for synthetic minor ampullate silk proteins

Expression of Synthetic Minor Ampullate Silk Proteins
The goals of the high-density cell culture outlined in this thesis were to maximize
the amount of MiSp in solution (soluble fraction) and minimize truncation so that the
majority of this protein was full-size MiSp. Flask culture studies were effective in
understanding how well these protein constructs expressed at low cell densities and how
the temperature after induction affected the expression levels of these large and repetitive
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Figure 2-7. Western blots of flask study hourly samples to determine expression
levels and solubility of MiSps; SF and IF denotes the soluble and insoluble fraction at
each hour after induction; arrow indicates full-size MiSp

proteins. The flask study experiments also yielded information on the solubility of the
protein constructs and how much of the expressed protein is stable in the soluble fraction
after translation. Figure 2-7 shows the western blot analysis for the hourly samples taken
during these flask study experiments when the temperature at induction was lowered to
30°C. Lanes 1-5 (SF0-SF4) on each membrane show the soluble fractions, while lanes 610 (IF0-IF4) show the insoluble fraction of each cell sample for each MiSp construct. At
the flask scale with the Terrific Broth media, OD600 varies between 1 and 3, so slight
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changes in protein expression and solubility are more readily noticeable than at high cell
densities. As expected, expression for the two smallest protein constructs (MiSp8 and
MiSp8s) is much higher than for the other four MiSp constructs of larger molecular
weight as seen in the top row of Figure 2-7. Furthermore, as the constructs get larger,
full-size protein is either not present, present in low quantities, or most of the full-size
protein is in the insoluble fraction. The largest construct that saw expression at this 30°C
induction temperature was MiSp16 at 68 kDa (second row left in Figure 2-7). A small
amount of full-size protein is present in the soluble fraction, with the majority in the
insoluble fraction. MiSp16s, MiSp24, and MiSp24s did not express at full size at
an induction temperature of 30°C and the bands present in the expression checks for these
constructs are highly truncated versions of the MiSp. At the flask scale, full-size
expression was not seen for MiSp24 and MiSp24s at any of the induction temperatures
tested. However, when the induction temperature was dropped to 22°C, full-size
expression was seen for MiSp16s (95 kDa) as shown in Figure 2-8, but MiSp16s still
showed significantly less expression than MiSp16. At this point, it was unclear whether
enough MiSp16s would be produced for purification even after high density culture.
Interestingly, the C-terminus antibody was also much more effective in detecting MiSp in
solution at low cell densities than the His-tag antibody. This was the first indication that
the His-tag at the N-terminus of the MiSp is not as readily available as the C-terminus
when the proteins are folded in solution.
In the interest of time and the goals of this thesis, benchtop bioreactor runs were
only performed for MiSp8, MiSp8s, MiSp16, and MiSp16s because full-size protein was
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Figure 2-8: Western blot of hourly samples from flask study expression checks for
22°C induction; SF and IF denote soluble and insoluble fractions at each hour after

not expressed at any induction temperature for the MiSp24 and MiSp24s constructs at the
flask scale. It is possible that the optimized expression of these constructs will involve the
investigation of alternative expression conditions and molecular machinery that may
nclude a different vector system28,47. The flask studies show that lower induction
temperatures are necessary especially for the larger MiSp constructs, although the
expression levels for MiSp16 and MiSp16s are lower than expected overall. The
benchtop bioreactor experiments were used to analyze how high-density culture with
OD600 values ranging from 80 to 100 may affect these expression conditions. Conditions
for growth in these experiments were kept constant, with the exception of temperature
and growth time after induction. Figures 2-9 and Figure 2-10 show expression at the
benchtop bioreactor scale for MiSp8, MiSp8s, MiSp16, and MiSp16s.
At this scale, , MiSp8, MiSp8s, MiSp16, and MiSp16s are expressing at full size
in the soluble fractions. As molecular weight increases, truncation becomes a more
significant issue and there is less full-size protein in the MiSp16 and MiSp16s soluble
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Figure 2-9. MiSp8 and MiSp8s hourly protein expression at the bioreactor scale in the
soluble fraction standardized to OD600 25

Figure 2-10. MiSp16 and MiSp16s hourly expression in the soluble fraction at the
bioreactor scale; samples standardized to OD600 25

fractions. As molecular weight increases, truncation becomes a more significant issue and
there is less full-size protein in the MiSp16 and MiSp16s soluble fractions than for
MiSp8 and MiSp8s. For the MiSp16s expression, there is a higher concentration of the
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truncated products overall. The His-tag antibody was used for all western blots at the
bioreactor scale because the His-tag is useful for detecting truncated forms of the MiSp.
However, especially in the case of the smallest constructs (MiSp8 and MiSp8s), the Histag antibody more readily attached to MiSps that are running ~10 kDa lower than full
size as seen in Figure 2-10. When the cell lysate samples are run with the C-terminus
antibody, two distinct conformations of MiSp are seen: one running at full size on the
SDS-PAGE, and one running ~10 kDa low as seen in the MiSp8s expression checks in
Figure 2-11. Because the C-terminus is evident in both conformations, it is reasonable to
assume both are full-size MiSp. Two other possible explanations could be that the protein
was degraded after translation or that the custom rSSp C-terminus antibody is not specific
enough. Degradation of the protein at the consistency seen in this high-density culture is
unlikely because only two conformations are seen when the C-terminus antibody is used
and they are seen in relatively high concentrations. Furthermore, the His-tag attaches to
both conformations of the protein in solution; however, it attaches to the lower band with
a much higher affinity as seen in Figures 2-9 and 2-10. Figure 2-11 also illustrates how
the C-terminus antibody does not show the truncated versions of the protein seen when
the His-tag antibody is used as in Figures 2-9 and 2-10.
To rule out the possibility that the lower band is an E. coli protein impurity that
binds to the C-terminus antibody, a blank BF115 benchtop bioreactor run was performed
under the same constraints that were used for the MiSp aerobic fermentations. Expression
checks were then performed on the hourly samples and a western blot was done using
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Figure 2-11. Western blot using C-terminus antibody; Lane S: 65 kDa MaSp1 (M4)
standard; Lane L: ladder; Lane SF soluble fraction MiSp8s lysate; Lane IF- insoluble
fraction from MiSp8s lysate

both the His-tag antibody and the C-terminus antibody. Figure 2-12 shows the soluble
and insoluble fractions of this “blank” expression test.
The C-terminus antibody did attach to an E. coli impurity in the insoluble fraction
of the cell lysate; however, no signal was seen in the soluble fraction as is evident in (A)
of Figure 2-12. Therefore, it can be determined that the two bands seen in the expression
checks of the MiSp high-density culture are both the target spider silk proteins.
Additionally, the purification of MiSp involves the isolation of only the soluble fraction,
so this E. coli impurity with an affinity to the C-terminus will be removed or mostly
removed in the first centrifugation. Further investigation showed that the C-terminus
antibody is less specific when used for insoluble pellet samples. Therefore, all additional
pellet samples were analyzed using the His-tag antibody because this antibody did not
result in any signal in either of the fractions as seen in (B) of Figure 2-12.

37

Figure 2-12. Hourly expression checks of soluble and insoluble fractions for blank
BF115 run. SF: soluble fraction, IF: insoluble fraction; (A) Western blot using Cterminus antibody. (B) Western blot using His-tag antibody.

Purification of Synthetic Minor Ampullate Silk Proteins

MiSp Extraction and Initial Purification Steps
MiSp8, MiSp8s, MiSp16, and MiSp16s were all extracted from the cell pellet
using the protocol described above. Each of these constructs was tested for their stability
at 80°C and with the addition of PEI to precipitate E. coli proteins and nucleic acids.
These treatments were necessary to substantially clean up the lysate in order for future
purification steps to be successful. Figure 2-13 illustrates this initial purification showing
the MiSp8 (40 kDa) lysate supernatant before and after the PEI and heat precipitations.
As seen in Lane 1 of Figure 2-13, the PEI and heat treatment are highly effective in
removing most of the protein impurities present in the lysate, leaving the target protein as
the most concentrated protein in solution.
These precipitations did result in minor protein losses for the MiSp8 (40 kDa),
MiSp8s, (53 kDa) and MiSp16 (68 kDa) constructs and more severe losses for the
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Figure 2-13. MiSp8 SDS-PAGE showing lysate initial purification with heat and PEI.
Lane 1- MiSp8 supernatant post-PEI treatment; Lane 2- MiSp8 pellet post-PEI
treatment; Lane 3- MiSp8 supernatant post-lysis with no treatment; MiSp8 pellet postlysis with no treatment

MiSp16s (95 kDa). While a fraction of MiSp16s protein is still present after PEI and heat
treatments, the concentration is substantially reduced when compared with the other
MiSp constructs, indicating that MiSp16s is not as stable in the soluble fractions as the
other three MiSps. Figure 2-14 shows the difference in concentration between MiSp16
and MiSp16s after PEI and heat treatments. This stability difference is notable and is
most likely due to the high molecular weight of the protein and not the presence of the
two spacer regions in this construct. You can see in Figure 2-14 that after PEI and heat
the majority of protein in solution is no longer the full-size MiSp16s depicted by the
arrow. By comparison, MiSp16 (68 kDa) showed good stability in solution after lysis,
heat, and PEI treatments and the majority of MiSp is full size, with acceptable levels of
truncated product still present.
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Figure 2-14. Lysate processing using heat and PEI as an initial purification. Lane 1:
MiSp16 (68 kDa) soluble fraction after heat and PEI treatments. Lane 2: MiSp16s (95
kDa) soluble fraction after heat and PEI treatments

The amount of full-size MiSp16 and MiSp16s produced by the cells in high
density culture was substantially lower than the smaller MiSp8 and MiSp8s constructs as
described in this chapter. The losses experienced by MiSp16s in this initial purification
step made downstream processes less viable for this construct from both a purity and a
yield standpoint. This initial purification step was constant for each of the MiSp
constructs going forward. The downstream processes and overall purifications for each of
the MiSps are shown in Figure 2-15.
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Figure 2-15. Purification strategies used in synthetic minor ampullate silk protein purification
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Nickel Affinity High Performance Liquid Chromatography
Taking advantage of the 6X histidine tag at the N-terminus of the MiSp
constructs, MiSp8 (40 kDa) and MiSp8s (53 kDa) were purified using this
chromatography method as they were soluble. These constructs were chosen as the trial
proteins for this purification method because their smaller size and increased expression
levels allowed for the best-case scenario in terms of yield and solubility of the four MiSp
constructs being expressed in the BF115 reactors. Previous studies have identified metal
affinity chromatography as a suitable small-scale purification method for synthetic spider
silk protein; however, most of these studies involved major ampullate
spidroins25,29,45,48,49.
The fractions collected after stepwise imidazole elutions from the column showed
full-size MiSp8 and MiSp8s in solution. Figure 2-16 shows the SDS-PAGE analysis of
the flow-through, wash, and elution fractions for the purification of MiSp8s.
There are substantial amounts of low molecular weight impurities in the eluted
fractions from the nickel column, as well as one high molecular weight impurity at ~90
kDa. These impurities are only seen on the Coomassie blue stained SDS-PAGE as they
do not show on a western blot analysis with the His-tag antibody, indicating that these
impurities are not full-size spider silk protein and should not bind independently to the
column. These issues persisted after repacking the column with fresh resin and
troubleshooting with a series of both MiSp8 and MiSp8s purifications.
Furthermore, the impurities could not be removed from the fractions by
centrifugal filtration, pH precipitation, or dialysis. This indicated that it was probable
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Figure 2-16. SDS-PAGE of MiSp8s nickel affinity chromatography purification.
Arrow indicates full-size MiSp8s. Lane 1: column flow through. Lane 2: column
wash. Lane 3: 5% imidazole elution. Lane 4: 10% imidazole elution. Lane 5-6: 100%
imidazole elution.

these protein impurities are interacting with the MiSp in solution, allowing them to bind
and be eluted from the column with the protein of interest.
Nickel affinity chromatography is one of the more laborious and expensive
methods for spider silk purification, especially at larger scales. Combined with the purity
issues seen with the MiSp purification on the Ni-NTA column, the yields for the MiSp8
and MiSp8s purifications averaged only ~15 mg rSSp/L aerobic fermentation. The low
yields may be the result of inconsistent column binding and elution of the MiSp in
solution—an issue that is likely due to the folding of the MiSps upon expression in E.
coli, which limits the accessibility of the His-tag. Because of these low yields, alternative
methods were explored to achieve yields that could sustain the goals of this thesis.
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Fractional Ammonium Sulfate Precipitations
As with nickel affinity chromatography, fractional ammonium sulfate
precipitations are frequently used in the purification of recombinant spider silk proteins to
obtain a protein pellet that can be then resolubilized in a concentrated “dope” for material
applications. For each synthetic MiSp construct, precipitations were done at varying
saturations with ammonium sulfate to identify a saturation point where all the MiSp was
removed from the soluble fraction. At 15% saturation and 4°C, each MiSp construct
(MiSp8, MiSp8s, MiSp16, and MiSp16s) could no longer be detected by western blot in
the soluble fraction, indicating that both conformations of MiSp seen in the lysate were
now in the pellet. The yields for this method were much better than with the
chromatography method, at about ~100-200 mg/L for each construct. Table 2-1 shows
the dry yields for each protein construct.

Table 2-1. Average dry weight totals for MiSp purification
with fractional ammonium sulfate precipitations
MiSp Construct

Average Dry
Yield (mg/L)

MiSp8

200

MiSp8s

187

MiSp16

182

MiSp16s

86

Upon precipitation, however, a marked decrease in solubility was seen to the
point that it was extremely difficult to resolubilize the pellet for analysis using SDS-
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PAGE. It was determined that the pellets were also completely insoluble under high heat
and pressure, in harsh organic solvents such as hexafluoroisopropanol (HFIP), and in
strong chaotropic salts such as guanidine thiocyanate and sodium dodecyl sulfate (SDS).
Because of this incredible level of insolubility, it was difficult to evaluate the purity of
the pellets and to verify that the protein was indeed present in the pellet sample due to the
fact that SDS-PAGE requires protein denaturation and solubility. Qualitative analysis
during the doping process under high heat and pressure indicated that the purity level was
high, as there was no observed color change or phase separation in the vial with
continued doping, even with the addition of propionic acid and ammonium hydroxide
(0.5M) at concentrations up to 5%.
To assess purity and verify the protein was not degraded or altered during the
precipitation, a wide variety of methods was attempted to solubilize the pellet and the
MiSps. Figure 2-17 shows sequential resuspensions and sonications of MiSp ammonium
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Figure 2-17. Urea and sarkosyl washes to verify MiSp in ammonium sulfate pellets.
Lane 1-MiSp8s; Lane 2- MiSp16; Lane 3- MiSp8 insoluble; Lane 4- MiSp8s; Lane 5MiSp8 insoluble; Lane 6- MiSp16s; Lane 7- MiSp16
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sulfate pellets with 8M urea and 2% sarkosyl, which eventually resulted in a very small
amount of solubilization and denaturation of the MiSps so that they could be analyzed
using SDS-PAGE and western blotting. In most of these cases, the protein concentration
was only high enough for western blotting and bands were not visible on the Coomassiestained polyacrylamide gel. To evaluate the purity of the pellet, enough of the MiSp8
pellet was eventually solubilized using sequential sonications with 8M urea, 2% sarkosyl,
and doping under high heat and pressure. Figure 2-18 shows this gel. This was the first

Figure 2-18. SDS-PAGE of partially solubilized MiSp8 (43 kDa) ammonium
sulfate pellet
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and only instance where enough of the ammonium sulfate protein pellet was solubilized
for visualization on a Coomassie-stained polyacrylamide gel. In every other case, the
concentration of soluble and denatured protein was only high enough for western blotting
visualization (<100 ng).
Although the concentrations of the other constructs in solution did not meet the
threshold to see a signal with the Coomassie stain, the MiSp8 pellet seen in Figure 2-18
reinforces what was qualitatively evident. The ammonium sulfate precipitation results in
an MiSp protein pellet with a high degree of purity. The insolubility of these pellets,
however, was a significant problem because they could not be solubilized in any solvent
for analysis, even at concentrations as low 1% w/v. Known issues in the expression and
purification of synthetic spider silks are the aggregation and natural insolubility of these
proteins both at the expression and purification stages; however, purified synthetic
MaSps are still soluble in HFIP and SDS in the worst-case scenarios. Information from
the literature has identified ammonium sulfate as one of the most viable methods for
protein stability and solubility50. Data from the Lewis lab and others report that the level
of aggregation and insolubility seen with MiSps at the ammonium sulfate step does not
occur in the purification of MaSps and chimeric silks from a bacterial platform31,35,25,38.
Further investigation with the precipitation of MiSps using dialysis showed a less
drastic, but similar level of insolubility seen with the ammonium sulfate precipitations.
Analysis of the pellets using FTIR did not show an increase in beta sheet structures;
aggregation of the MiSps in the insoluble fraction therefore is the likely cause of the
insolubility and it is not a result of structural changes occurring upon precipitation.
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Increasing the precipitation time and slowly (0.5 ml/minute) adding solubilized
ammonium sulfate to the clarified lysate to avoid the “crash” of the MiSp out of solution
failed to improve the solubility of the pellet. Because of this, no material applications
could be explored following this purification method.

Ethanol/Isopropyl Alcohol/Acetone Precipitations
Although the fractional ammonium sulfate precipitations succeeded from a
purification standpoint, alternate precipitation methods were explored so that the
synthetic MiSps could be investigated for material applications. Ethanol, isopropyl
alcohol (IPA), and acetone were chosen as potential alternatives because preliminary
investigations showed that upon precipitation with these solvents, the MiSps were much
more soluble so they could be denatured in SDS and analyzed. The reasons for this
solubility difference are relatively unclear as the modes of action of precipitation between
these methods aren’t inherently that different. In the alcohol/IPA/acetone precipitations
however, the precipitation of MiSps happens instantaneously, which may not allow for
the levels of protein binding and aggregation seen with methods like dialysis and
ammonium sulfate where the concentration of free water diminishes more slowly.
Alcohol precipitations also result in more impurities in the precipitate and are far less
specific when it comes to the complete precipitation of both conformations of MiSp in a
single step, as was achieved with the ammonium sulfate precipitation. The presence of
these impurities may also interrupt the aggregated complex of MiSps that exhibited such
incredible levels of insolubility. While obtaining more soluble MiSps was a positive
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aspect of these methods, significant investigation was necessary to evaluate which
combinations and concentrations of these solvents were needed to effectively precipitate
both conformations of MiSp and still arrive at an acceptable purity level for material
applications to be successful.
The MiSp8, MiSp8s, and MiSp16 constructs underwent initial precipitations with
each of these solvents and ethanol was identified as the best of the three solvents for
precipitation of impurities because MiSps were very stable in high concentrations of
ethanol. Interestingly, the stability in solution and solubility of each of these constructs
decreased with molecular weight. Figure 2-19 shows the complete purification of MiSp8
from the heat/PEI step through to the ethanol precipitation pellet. The MiSp8 (40 kDa)
precipitated after the concentration of ethanol reached 30% (v/v), while the MiSp8s (53
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Figure 2-19. MiSp8 purification. Lane 1: MiSp8 clarified lysate post heat and PEI
treatments; Lane 2: discarded pellet from PEI and heat treatments; Lane 3: MiSp8
pellet from a 30% ethanol cold precipitation, arrow indicates MiSp8 in final pellet
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kDa) required an overnight precipitation or an additional 10% (v/v) precipitation to fall
out of solution and much of the MiSp8s remained in solution under these circumstances.
MiSp8 was best-suited for the alcohol precipitations because it exhibited the
highest purity and best recovery when compared with the other constructs. The MiSp16
was the most difficult protein to precipitate out of solution using the
alcohol/IPA/acetone precipitation method. Figure 2-20 shows MiSp16’s stability in
sequential precipitations using both ethanol and IPA. MiSp16 was stable in solution at
concentrations up to 40% ethanol and 20% IPA, with minimal losses. This was
convenient from a purification standpoint because the ethanol and IPA precipitations
remove many non-protein impurities that have been known to cause problems
downstream. However, these precipitations did not remove the low molecular weight
protein impurities that also plagued the chromatography method and resulted in minimal
losses of the smaller conformation of MiSp, which do not show with the His-tag antibody
but do show with the C-terminus antibody. The lower molecular weight conformation of
MiSp that was described in this chapter was shown to be less soluble than the higher
molecular weight band; however, it is still believed to be full-size MiSp. To precipitate
the rest of both conformations of MiSp16, an additional 20% acetone purification was
used following the ethanol and IPA treatments. Figure 2-21 shows the pellets with
varying concentrations of acetone.
The purification of MiSp16s using these methods was not viable because it was
not stable enough to stay soluble following the initial PEI and heat purification step,
which was an imperative step in this process due to the purity problems that presented
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Figure 2-20. MiSp16 ethanol/IPA precipitations. Left: SDS-PAGE; Right: Western
blot with His-tag antibody; Lane 1: 10% IPA/25% EtOH super; Lane 2: 10% IPA/25%
EtOH pellet; Lane 3: 15% IPA/25% EtOH super, Lane 4: 15% IPA/25% EtOH pellet;
Lane 5: 20% IPA/25% EtOH super; Lane 6: 20% IPA/25% EtOH pellet; Lane 7: 30%
IPA/25% EtOH super; Lane 8: 30% IPA/25% EtOH pellet; Lane 9: 20% IPA/40%
EtOH super; Lane 10: 20% IPA/40% EtOH pellet
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Figure 2-21. MiSp16 ethanol/IPA/acetone pellets; Lane 1: 10% acetone pellet; Lane
2: 15% acetone pellet; Lane 3: 20% acetone pellet
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themselves even after most of the E. coli proteins and nucleic acids were removed from
that initial clean-up step. Table 2-2 shows the yields from these methods. Note that the
yields are slightly higher than seen in the ammonium sulfate method; however, purity
levels have to be considered in that analysis.

Table 2-2. Average dry weight yields for ethanol/IPA/acetone precipitations

MiSp Construct

Average Dry Yield
(mg/L)

MiSp8

250

MiSp8s

228

MiSp16

192

MiSp16s

n/a

These precipitations using alcohols and acetone were effective in that they
produced synthetic MiSps that were markedly more soluble in the pellet form. This pellet
could then be utilized in concentrated dopes for material applications; however, the purity
was not at the level seen with the ammonium sulfate precipitations. These purity issues
are unavoidable with this method because it requires high concentrations of alcohol or
acetone to precipitate the MiSps, which also precipitates protein and non-protein
impurities that remain in the clarified lysate. These impurities have been known to
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present problems with protein workability and mechanical properties; however, the
sacrifice of purity was necessary in these cases to avoid the solubility issues and move
forward with the project goals.

PRELIMINARY BIOPHYSICAL CHARACTERIZATION OF SYNTHETIC MINOR
AMPULLATE SILK PROTEINS
The preliminary characterization of aqueous minor ampullate silk proteins and
their material applications allows for the first comparison between synthetic analogs of
minor ampullate silk proteins and how the properties of MiSp films depend on
purification processing, protein sequence, and protein molecular weight.
FTIR spectra including the Amide I (1600-1700 cm-1) and Amide II (1500-1600
cm-1) regions for MiSp8, MiSp8s, MiSp16, and MaSp1 (transgenic goat-derived) are
shown in Figure 5-2. Goat-derived MaSp1 (65 kDa) was used as a control/comparison in
these studies because it has similar sequence and structural motifs to the MiSps. Data is
limited on Nephila clavipes MaSp1 produced from a bacterial platform; therefore, the
goat-derived protein was the best alternative for a comparison. Figure 2-22 shows that
MaSp1, MiSp8, and MiSp16 deviate little in their spectra and exhibit predominantly βsheet structures. However, the MiSp8s and MiSp16s spectra have a clear left shift. This
indicates a transition to primarily α-helical/random coil structures.

53

1624

1530

Figure 2-22. FTIR spectra of rSSps; 1624 cm-1 and 1530 cm-1 peaks mark prominent
β-sheet regions in Amide I and Amide II

To further analyze the spectra and this shift, the Amide I region was deconvoluted
and Figure 2-23 shows these deconvolution results. The Amide I region was chosen for
deconvolution because it is the primary amide vibration band and its vibration depends

54
A
Construct

β- sheet (%)

α-helix/random coil (%)

MaSp1

60

29

MiSp8

65

25

MiSp8s

23

76

MiSp16

60

36

MiSp16s

19

77

B

Figure 2-23. FTIR deconvolution results; A: Summary of deconvolution results; B:
Deconvolution of Amide I of the IR spectra with peak centers at 1620, 1650, and 1698
cm-1
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on the secondary structure of the protein backbone, without hinderance from the
nature of the residues’ side chains52. The three characteristic peaks used for the
deconvolution were 1624 cm-1, 1650 cm-1, 1698 cm-1, which have been identified as
reliable indicators of protein secondary structure in silk structural analyses using both
FTIR and Raman spectroscopy51,52. Figure 2-23 (B) indicates the secondary structure
assignments to these characteristic peaks53. All of the constructs had similar relative
percentages of β-sheet and α-helical/random coil structures, with the exception of
MiSp8s and MiSp16s. Figure 2-23 (A) shows these integration results. These were very
interesting results because no definitive secondary structure has been directly associated
with the spacer region; however, it has been hypothesized that the spacer region is
composed mainly of α-helical structures, does not participate in β-sheet structures, and
may also serve as a matrix to embed the crystalline regions13. The FTIR spectra of the
MiSp8s and MiSp16s protein in this investigation adds evidence to these hypotheses
because there is a definitive and significant shift towards α-helical/random coil structures
compared with the MiSp8 and MiSp16 constructs.
From this preliminary characterization, it can be deduced that the addition of the
spacer region adds significant α-helical structures to the protein’s identity; however, it is
unclear if the repetitive regions of MiSp8s and MiSp16s were unable to fold into their
correct secondary structure due to the low β-sheet percentages seen from the
deconvolution compared with MiSp8 and MiSp16.
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To further characterize these spidroins and test their properties in material
applications, films from an aqueous dope were created and tested. The protein pellets
from the ethanol/IPA/acetone precipitations had to be used to complete this project goal
because the insolubility of the ammonium sulfate pellets eliminated them for material
applications. These pellets were significantly less pure than the ammonium sulfate
pellets, and that may have had an effect on the mechanical properties of the aqueous
films. Table 2-3 displays tensile mechanical properties. As expected based on the
findings of prior publications, higher molecular weight was correlated with a higher
average stress45. However, none of the stress values were statistically different from each
other. Interestingly, the MiSp8s had just as high of an average stress value as the other
rSSp constructs, which were determined to have a much higher β-sheet content from
FTIR analysis; therefore, the helices in MiSp8s contribute substantially to tensile
strength.

Table 2-3. Tensile data for rSSps aqueous films
rSSp

Average
Max Stress
(MPa)

Average
Max Strain
(%)

MiSp8 (40 kDa)

20.54 ± 8.37

2.9 ± 1.1*

MiSp8s (53 kDa)

25.9 ± 3.0

2.7 ± .1*

MiSp16 (67 kDa)

30.67 ± 4.24

3.3 ± 0.2*

MaSp1 (65 kDa)

39.1 ± 8.52

1.8 ± .2

* denotes significance p <.05
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It has also been hypothesized that the presence of the spacer region may be the
cause of the inelasticity of minor ampullate silk because it irreversibly deforms upon
stretching13. The MiSp aqueous films used in this study therefore could not be stretched
before testing. This stretching has been shown to increase tensile strength and strain in
recombinant MaSps, possibly as a result of the alignment of the protein chains36.
Therefore, the low strain value of the MaSp1 in Table 2-3 is somewhat deceptive, as
unstretched MaSp1 was used for comparison with the MiSp aqueous films. Using
established methods for film post-treatment and stretching, aqueous MaSp1 films can
experience an increase in tensile stress by 2.5x and strain by 18x36. Due to the small
sample sizes available in this study, significant investigation into post-treatments and
stretching ratios could not be explored for the MiSp films. However, compared with
unstretched MaSp1, the MiSp films all had higher strain values, which were significant.
Based on what is known about the sequence of MiSp and its mechanical properties in
nature, it is not known whether custom post-treatment methods can be used to increase
these strain values. However, it is likely that future work with MiSp film treatments and
processing could significantly increase the tensile strength, as is seen with the
recombinant MaSps. Possible film treatments include dope additives, alcohol baths, and
ratios of film stretching.
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CHAPTER 3
CONCLUSIONS

This is the first known investigation involving synthetic recombinant minor
ampullate silk proteins. The study of synthetic spider silk proteins has largely been
confined to the major ampullate silks, however understanding the expression and
purification considerations for other silk proteins may expand the material possibilities
for synthetic spider silk industrial use. Using synthetic protein analogs may also shed
light on how protein sequence motifs translate to secondary structure and mechanical
properties. In this investigation, six synthetic MiSp constructs with varying iterations of
characteristic protein motifs were created for expression in E. coli. These proteins were
then successfully expressed at full-length in high-density cell culture at molecular
weights ranging from 40 to 95 kDa.
Protein expression and extraction were more efficient with the lower molecular
weight constructs and two conformations of MiSp could be detected in the soluble
fraction depending on the antibody used, which was likely due to folding inconsistencies
in high-density culture.
In order to study these protein analogs, four general purification methods were
used: an initial lysate purification using PEI and heat treatments, nickel affinity
chromatography, fractional ammonium sulfate precipitations, and ethanol/IPA/acetone
precipitations. MiSp’s folding patterns introduced challenges in purification, as the
expressed proteins exhibited a limited accessibility to the 6x-His tag. As a result, nickel
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affinity chromatography produced yields that were too low to support the goals of this
project. Furthermore, low molecular weight impurities interacting with the MiSps in
solution created purity problems throughout the purification processes.
Fractional ammonium sulfate precipitations produced an MiSp pellet that
exhibited the highest purity level of all the purification methods, however protein
aggregation resulted in a totally insoluble pellet that prevented use of the protein for all
material applications. In order to precipitate the protein and solubilize the pellet in high
concentration dopes for material applications, ethanol/IPA/acetone precipitations had to
be used to preserve the solubility of the MiSps. The solubility difference of these solventextracted pellets could be due to the lower purity of the final pellet or it could be due to
the rapid phase change the proteins undergo when exposed to the solvents. This method,
although effective from a solubilization standpoint, was not ideal due to the fact that the
solvent precipitations were not selective, which resulted in some MiSp left in solution
and/or more impurities in the final pellet that may have interfered with mechanical
properties of the materials.
A preliminary structural investigation and comparison was done using FTIR-ATR
spectroscopy, which showed very little difference in secondary structure between MiSp8,
MiSp16, and goat-derived MaSp1. These proteins all exhibited predominantly β-sheet
structures, with ~20% α-helices contributing to the spectra. However, the MiSp8s and
MiSp16s proteins including the spacer region(s) showed a definitive shift in the spectra
and its secondary structure exhibited significant α-helices. This is the first defined
characterization of the spacer region.
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For information on how these secondary structures transfer to mechanical
properties, aqueous MiSp films were created for tensile testing and compared to each
other and unstretched, goat-derived MaSp1. The tensile stress of these films were not
significantly different from each other or MaSp1. However, the strain values were all
significantly higher than the strain of unstretched MaSp1. This result is interesting, but it
must be also considered that the more characterized MaSp1 films experience increases in
tensile properties when they are processed in a series of post-treatments that include a
variation of stretch baths36. The sample sizes in this study were inadequate for an indepth investigation of film processing as has been done previously for the MaSps,
however it is likely that with processing MiSp films would also see an increase in tensile
strength. Since these proteins are naturally inelastic, it is unlikely that MiSp films would
see the elongation increases seen for MaSps—allowing them to fill different niches in
product applications, such as ballistics.

Future Work
While this investigation yielded the first information on synthetic minor ampullate
silk proteins, more work needs to be done to improve extraction efficiency, yields,
protein purity, and material mechanical properties. While four MiSps were produced in
the soluble fraction of high-density culture, there are folding inconsistencies of the fullsize protein that are not yet fully understood. This causes variation in the behavior of the
MiSps in solution, which complicates purifications that take advantage of protein charge,
solubility, and folding and ultimately affects the yield and purity of the processes.
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MiSp16s showed a high instability in solution after extraction, which resulted in an
inability to purify it for use in aqueous films. Future work will require an investigation of
the stability requirements for these proteins after lysis, as well as what can be done to
prevent the aggregation and insolubility issues presented with the fractional ammonium
sulfate precipitations. This may also require alternative purification methods such as ionexchange chromatography, size exclusion chromatography, or reverse-phase
chromatography. Investigating these other chromatography methods allows for an
opportunity to significantly clean up the clarified lysate before precipitation, as the
precipitation step was identified in this investigation as a critical step that always
introduced either purity and/or insolubility issues.
Using these synthetically produced spidroins, more work can be done to study the
structural implications of the arrangement and prevalence of MiSp’s amino acid motifs.
Investigating the processing and post-treatment of aqueous films may contribute to this,
as it is still unclear if mechanical properties of these films may be enhanced, as is seen
with MaSp aqueous films.

Engineering Significance and Innovation

Significance
The functional diversity of spider silks creates unique opportunities for robust,
biocompatible, and ecofriendly alternatives for a variety of polymer applications35,37,55–59.
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Because of the unique properties of spider silks, significant research efforts have focused
on the native protein sequences and folding structures. Among this research, most
investigations focus on the major ampullate silks. This is due to factors that include the
impressive combination of strength and elasticity seen in the dragline silk, the large size
of the major ampullate gland, and the fact that the native dragline silk fibers can be more
easily isolated from the spider for fiber and protein characterization40. While the
sequences of the other six silks have been determined, significantly less research has been
done on their folding structures and mechanical properties. For most of the silks, little to
no research has been published on their synthetic production making them difficult to
study and further characterize for potential material applications.
Minor ampullate silk is one of these lesser studied silks that possesses properties
that could be well suited for many applications. Native minor ampullate silk is difficult to
harvest because the natural fibers are significantly smaller in diameter than other spider
silk fibers and no minor ampullate silk is easily identifiable in the orb web because it is
used as a template for the capture spiral and most species later replace it with flagelliform
silk3. Therefore, studying minor ampullate silk proteins synthetically makes it possible to
study the protein sequences and their subsequent folding structures and how the
production of these proteins compares with the production of other spider silk proteins,
namely the major ampullate silk proteins11.
Because of the limited published investigations into synthetic analogs of most of
the spider silk proteins, engineering the production and purification of these proteins is
novel and requires extensive planning, testing, and revision as was evident in this thesis.
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The folding mechanisms of synthetic spider silk proteins are still not entirely understood,
therefore we do see folding inconsistencies and insolubility issues in the synthetic
production and purification of spider silk proteins. Interestingly, these issues present
differently and are more drastic for certain silks compared with others. This may be one
of the reasons that there are so few published investigations of synthetic spider silk
proteins that are not the MaSps. Investigations like these are needed to understand how
sequence motifs, molecular weight, and secondary structure of each of the proteins may
be considered to engineer expression and purification methods that are specifically
designed for each spider silk protein. Many of the problems associated with expression
and purification are similar and solutions may be deduced from the further study of many
different spider silk proteins that have slight modifications to their sequence and folding
structures.
These investigations also have the potential to expand the opportunities for these
proteins and their potential use in industry. The spider silk gene family is diverse and the
mechanical properties that each silk possesses could result in material applications for a
wide variety of industries that include textiles, medical, ballistics, outdoor etc.

Innovation
This thesis, combined with other investigations, has significantly broadened the
knowledge of how protein sequence translates to secondary structure and mechanical
properties. This may allow for the construction of new chimeric silks that could be tuned
for the selection of certain properties. Each of the seven spider silks possesses properties
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that could diversify the portfolio for potential material applications and products. For
example, major ampullate silk is bulletproof by nature and can absorb and dissipate high
amounts of energy, but its elasticity disqualifies it for real-life ballistic applications.
Minor ampullate silk, on the other hand, achieves a high tensile strength while
maintaining an elongation that is identical to Kevlar5. Ballistic recombinant spider silk
materials would also be environmentally friendly to produce and more lightweight than
their competitors5.
Another interesting property of minor ampullate silk is that it does not
supercontract in water, which is a phenomenon seen in the major ampullate silk that is
not entirely understood. Previous studies have shown that major ampullate silk’s tensile
properties are affected significantly more than minor ampullate silk properties when
tested in water due to the plasticizing effect of supercontraction. This might be due to the
fact that MiSps are more crystalline than MaSps, causing a lower loss of orientation when
exposed to water57. It has been hypothesized that the proline content of the silk protein
may also be a contributing factor. This must be accounted for when developing materials
that have high exposure to moisture and aqueous environments, such as medical materials
or implants. Tuning the crystallinity of a chimeric silk or combining a variation of silk
proteins could result in a polymer material that possesses a variation of the sought-after
properties of silks.
Based on the findings of this thesis, the highly conserved spacer region
contributes helical structures to the final protein structure. These helices have been
known to contribute to tensile strength and, based on expression results in this thesis, may
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allow for the construction of higher molecular weight silk proteins due to its
nonrepetitive nature.

Potential Drawbacks and Cost Analysis
The synthetic production of these proteins in transgenic systems remains a
limiting factor in the design of prototype materials and their subsequent use in industry.
Referring Figure 1-533, rSSp production in bacterial systems needs to reach yields of 10
g/l of fermentation to compete with fiber materials such as Kevlar, which sell for about
$20-$30/kg60. However, non-fiber applications such as films, coatings, adhesives,
lyogels, hydrogels, and foams typically require much less protein than fibers do, which
increases the cost-effectiveness of rSSps for these materials35. MiSp yields from E. coli
have been shown in this thesis to be low (~100-300 mg/L) compared with other reported
yields of rSSps like MaSp2 (800 mg-2 g/L)26,29,49,54. Similar low yields in bacterial
systems, such as those seen for the MiSps, have been reported for high molecular weight
constructs of MaSp1. This is likely due to the fact that MaSp2 has been the subject of
more studies as far as synthetic production is concerned. More research needs to be done
to optimize the parameters of cell growth, protein expression, protein extraction, and
purification methods for these protein constructs to maximize yields and purity to
increase the likelihood that synthetic rSSps may be used in industrial products.
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APPENDIX A
INVESTIGATION OF A COLD SHOCK VECTOR SYSTEM
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Background
In 2004, Takara Bio developed a series of cold-shock expression vectors (pColdI,
pColdII, pColdIII, and pCold IV)61. These systems regulate gene expression using the
cspA promoter, which exhibits up-regulation at growth temperatures of 15°C62. This,
coupled with an upstream lac operator sequence prevents leaky expression at 37°C and
allows for gene expression and protein translation to occur at low temperatures after the
addition of IPTG. The vector also includes a translation-enhancing element (TEE) and a
6x-His tag. This process allows expression of the target protein at high yields, while
suppressing cell growth and the expression of other cellular proteins. A vector map of
pColdII is shown in Figure A-1.

Figure A-1. Vector map of pColdII

73
These vectors are currently being explored as an alternate choice for recombinant
spider silk protein production as well as for the production of other eukaryotic proteins63.
These large and repetitive proteins exhibit both expression and solubility limitations upon
expression in E. coli, which may make them prime candidates for a cold-shock
expression system.

Materials and Methods

MiSp-pColdII Constructs
The linearized synthetic MiSp constructs MiSp8 and MiSp16 were ligated into
pColdII using the restriction sites BamHI and NdeI in the multiple cloning site of the
expression vector. Figure A-2 shows these final digested constructs, which were verified
by sequencing (ACTG, Inc).

MiSp16

MiSp8

Figure A-2. MiSp-pColdII digested constructs
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MiSp-pColdII Preliminary Flask Study
Once the synthetic MiSp-pColdII constructs had been verified, a preliminary flask
study was performed to evaluate expression levels of MiSp8. In order to effectively
compare the expression levels between the pColdII system and the pET19kt system, two
side-by-side 1L flask studies were done using MiSp8-pColdII and MiSp8-pET19kt.
Overnight cultures of a single colony of each construct were used to inoculate both flasks
containing Terrific Broth media as was described in Chapter 2. Both flasks were
incubated at 37°C and 200 RPM until OD600 values reached 0.6 to 0.8. At this point, the
pColdII flask was removed from the incubator and chilled on ice until the temperature of
culture dropped to 15°C. Both flasks were then inoculated with a final concentration of
1mM IPTG. After induction with IPTG, the pColdII flask was incubated at 15°C and the
pET19kt flask was incubated at 25°C according to the protocol in Chapter 2. Both flasks
were incubated for 24 hours after induction.
Unfortunately, the pColdII vector has not yet been adapted to include the Cterminus region that the pET19kt vector includes so western blot analysis of the hourly
samples had to be done using the His-tag antibody to compare the expression to the
pET19kt expression system. Expression tests and SDS-PAGE analysis was done
according to the protocol in Chapter 2.

Preliminary Results and Discussion
Recombinant spider silk proteins have traditionally been difficult to express in
bacterial systems like E. coli due to significant truncation of the full molecular weight
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product and improper folding that results in insoluble inclusion bodies that are difficult to
extract and purify.
Because the pColdII vector lacks the C-terminus coding region, analysis had to be
done using the His-tag antibody instead of the C-terminus antibody. This was not ideal,
as the prior flask studies carried out in this thesis showed that the folding of MiSps limit
the accessibility of the His-tag and it was difficult to get a strong signal at the low protein
expression levels available at the flask scale, whereas the C-terminus antibody gives a
much stronger signal at these low expression levels. The expression checks showing the
soluble fractions of both of these flask studies are shown in Figure A-3. It’s seen in this
western blot analysis that expression of MiSp8 was evident in both the pColdII and
pET19kt flask, however this preliminary flask study shows that the pET19kt flask may
have resulted in higher expression levels than the pColdII flask. The MiSp8 expressed in
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Figure A-3. His-tag western blot of pColdII and pET19kt expression of MiSp8. Lanes
1-4: soluble fractions of pColdII flask at hours 4, 16, 21, 24 after induction; Lanes 5-8:
soluble fractions of pET19kt flask at hours 4, 16, 21, and 24 after induction
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the pColdII system does appear to have lower levels of truncation. This lower level of
truncation is to be expected based on the low induction and incubation temperature.

Conclusions
Two synthetic MiSp constructs (MiSp8 and MiSp16) were ligated into a pColdII
expression vector for expression analysis compared to a pET19kt expression system. A
preliminary flask study exhibiting a side-by-step 24 hour induction of MiSp8 showed that
the pColdII vector did not show significantly higher expression in the soluble fraction of
recombinant protein when compared to pET19kt, however it does appear to result in
lower levels of truncation. This may be significant at larger scales where truncation
becomes an issue at higher OD600 values. Because pColdII carries an ampicillin resistance
gene, benchtop bioreactor studies were not done to evaluate these truncation levels at
higher OD600 values. Ampicillin is not compatible with high-density, as beta-lactamase
causes degradation problems in high-density culture.
Future work needs to be done to evaluate how well this expression system may
work with the production and purification of synthetic MiSps. In order to work with this
vector in high-density culture, a kanamycin adapter needs to be cloned in and more
analysis needs to be done on the expression and truncation levels of each recombinant
spider silk protein. Data from this thesis and from literature indicate that lower induction
temperatures help with the truncation and overall yield of these proteins, therefore a coldshock vector system like pColdII may be a suitable alternative to pET series vectors.
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APPENDIX B
SYNTHETIC RECOMBINANT MINOR AMPULLATE SILK PROTEIN SEQUENCES
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**C-termini highlighted in blue and spacer regions highlighted in yellow**

MiSp8
MTGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGA
GAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAG
AGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAG
AGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAG
AGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAG
AGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGA
GGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGA
GAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGA
GGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGA
GAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAG
GYGGQGGYGAGAGAGAAAAAGAGASGGDPGSASRLASP
DSGARVASAVSNLVSSGPTSSAALSSVISNAVSQIGASNP
GLSGCDVLIQALLEIVSACVTILSSSSIGQVNYGAASQFAQ
V V G Q S V L S A F A A Stop

MiSp8s
M T G G G S S A G N A F A Q S L S S N L L S S G D F V Q Met I S S T T S T D E A
V S V A T S V A Q N V G S Q L G L D A N A Met N N L L G A V S G Y V S T L G N
AISDASAYANALSSAIGNVLANSGSISESTASSAASSAASS
VTTTLTSYGPAVFYAPSASSGGSGGAGGYGRGAGAGAGA
AAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAG
GYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGA
AAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGG
QGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAA
AGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGG
YGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAA
AAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQ
GGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAA
GAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGY
GRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAA
AAGAGASGGDPGSASRLASPDSGARVASAVSNLVSSGPT
SSAALSSVISNAVSQIGASNPGLSGCDVLIQALLEIVSACV
T I L S S S S I G Q V N Y G A A S Q F A Q V V G Q S V L S A F A A Stop
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MiSp16
MTGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGA
GAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAG
AGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAG
AGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAG
AGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAG
AGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGA
GGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGA
GAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGA
GGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGA
GAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAG
GYGGQGGYGAGAGAGAAAAAGAGASGGAGGYGRGAGA
GAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGA
GGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGA
GAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAG
GYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAG
AGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAG
GAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAG
AGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGG
YGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGA
GAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGG
AGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGA
GAAAAAGAGASGGDPGSASRLASPDSGARVASAVSNLVS
SGPTSSAALSSVISNAVSQIGASNPGLSGCDVLIQALLEIV
S A C V T I L S S S S I G Q V N Y G A A S Q F A Q V V G Q S V L S A F A A Stop
MiSp16s
MTGGGSSAGNAFAQSLSSNLLSSGDFVQMISSTTSTDEAV
SVATSVAQNVGSQLGLDANAMNNLLGAVSGYVSTLGNAI
SDASAYANALSSAIGNVLANSGSISESTASSAASSAASSVT
TTLTSYGPAVFYAPSASSGGSGGAGGYGRGAGAGAGAAA
GAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGY
GRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAA
AAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQG
GYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAG
AGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYG
RGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAA
AGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGG
YGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGA
GAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGR
GAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAA
GAGASGGGSSAGNAFAQSLSSNLLSSGDFVQMISSTTSTD
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EAVSVATSVAQNVGSQLGLDANAMNNLLGAVSGYVSTL
GNAISDASAYANALSSAIGNVLANSGSISESTASSAASSA
ASSVTTTLTSYGPAVFYAPSASSGGSGGAGGYGRGAGAG
AGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAG
GAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAG
AGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGG
YGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGA
GAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGG
AGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGA
GAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGY
GGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAG
AAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGA
GGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAG
AAAAAGAGASGGDPGSASRLASPDSGARVASAVSNLVSS
GPTSSAALSSVISNAVSQIGASNPGLSGCDVLIQALLEIVS
A C V T I L S S S S I G Q V N Y G A A S Q F A Q V V G Q S V L S A F A A Stop

MiSp24
MTGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGA
GAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAG
AGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAG
AGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAG
AGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAG
AGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGA
GGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGA
GAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGA
GGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGA
GAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAG
GYGGQGGYGAGAGAGAAAAAGAGASGGAGGYGRGAGA
GAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGA
GGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGA
GAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAG
GYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAG
AGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAG
GAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAG
AGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGG
YGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGA
GAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGG
AGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGA
GAAAAAGAGASGGAGGYGRGAGAGAGAAAGAGAGAGG
YGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGA
GAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGG
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AGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGA
GAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGY
GGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAG
AAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGA
GGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAG
AAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYG
GQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGA
AAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGASGGD
PGSASRLASPDSGARVASAVSNLVSSGPTSSAALSSVISN
AVSQIGASNPGLSGCDVLIQALLEIVSACVTILSSSSIGQV
N Y G A A S Q F A Q V V G Q S V L S A F A A Stop

MiSp24s
MTGGGSSAGNAFAQSLSSNLLSSGDFVQMISSTTSTDEAV
SVATSVAQNVGSQLGLDANAMNNLLGAVSGYVSTLGNAI
SDASAYANALSSAIGNVLANSGSISESTASSAASSAASSVT
TTLTSYGPAVFYAPSASSGGSGGAGGYGRGAGAGAGAAA
GAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGY
GRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAA
AAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQG
GYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAG
AGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYG
RGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAA
AGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGG
YGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGA
GAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGR
GAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAA
GAGASGGGSSAGNAFAQSLSSNLLSSGDFVQMISSTTSTD
EAVSVATSVAQNVGSQLGLDANAMNNLLGAVSGYVSTL
GNAISDASAYANALSSAIGNVLANSGSISESTASSAASSA
ASSVTTTLTSYGPAVFYAPSASSGGSGGAGGYGRGAGAG
AGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAG
GAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAG
AGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGG
YGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGA
GAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGG
AGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGA
GAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAGAGGY
GGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAGAGAG
AAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAGAGGA
GGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAGAGAG
AAAAAGAGASGGGSSAGNAFAQSLSSNLLSSGDFVQMIS
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STTSTDEAVSVATSVAQNVGSQLGLDANAMNNLLGAVSG
YVSTLGNAISDASAYANALSSAIGNVLANSGSISESTASSA
ASSAASSVTTTLTSYGPAVFYAPSASSGGSGGAGGYGRG
AGAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAG
AGAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYG
AGAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGA
GAGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGA
GAGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGA
GAGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGA
GAGAGAAAAAGAGAGGAGGYGRGAGAGAGAAAGAGAG
AGGYGGQGGYGAGAGAGAAAAAGAGAGGAGGYGRGAG
AGAGAAAGAGAGAGGYGGQGGYGAGAGAGAAAAAGAG
AGGAGGYGRGAGAGAGAAAGAGAGAGGYGGQGGYGAG
AGAGAAAAAGAGASGGDPGSASRLASPDSGARVASAVSN
LVSSGPTSSAALSSVISNAVSQIGASNPGLSGCDVLIQALL
EIVSACVTILSSSSIGQVNYGAASQFAQVVGQSVLSAFA
A Stop

